Our News on Newswise

2022 Alzheimer’s Disease Facts and Figures Report; experts available


3-Mar-2022 11:05 AM EST Add to Favorites

Global Dementia Cases Forecasted to Triple by 2050

Positive trends in global education access are expected to decrease dementia prevalence worldwide by 6.2 million cases by the year 2050.
28-Jul-2021 8:05 AM EDT Add to Favorites

Alzheimer's Association Welcomes CMS Announcement of National Coverage Determination Analysis on Treatment for Alzheimer's Disease

On behalf of all those living with Alzheimer's disease, their caregivers, and their families, we appreciate the Centers for Medicare & Medicaid Services (CMS) thoughtful consideration on coverage considerations for monoclonal antibodies targeting...
13-Jul-2021 8:45 AM EDT Add to Favorites

Ensuring Timely, Appropriate And Equitable Access To Aduhelm

Aduhelm has been approved for use for those with Mild Cognitive Impairment or early stage Alzheimer's dementia. This treatment offers a marginal but potentially meaningful slowing of decline for this subpopulation of individuals with Alzheimer's...
12-Jul-2021 8:45 AM EDT Add to Favorites

Alzheimer's Association Welcomes Revised Label For Aduhelm

The Alzheimer's Association is pleased with the announcement today that the Food and Drug Administration (FDA) has revised the prescribing label for Aduhelm™ (aducanumab).
8-Jul-2021 6:00 PM EDT Add to Favorites

Alzheimer's Association Statement: Next Steps For New Alzheimer's Treatment

As the global nonprofit leader in Alzheimer's research and science we have extensively reviewed the clinical trial data for Aduhelm™ (aducanumab).
14-Jun-2021 8:05 AM EDT Add to Favorites

Newswise: Tuesday_1130_Blood_Biomarkers_Social_Graphic.jpg

A Blood Test for Alzheimer’s? Markers for TAU Take Us a Step Closer

A simple blood test for Alzheimer’s would be a great advance for individuals with — and at risk for — the disease, families, doctors and researchers.
27-Jul-2020 9:05 AM EDT Add to Favorites

Primary Care Physicians on the Front Lines of Diagnosing and Providing Alzheimer’s and Dementia Care: Half Say Medical Profession Not Prepared to Meet Expected Increase in Demands

- Report provides latest Alzheimer’s prevalence, incidence, mortality and costs of care data - - Barring medical breakthroughs, the number of people age 65+ with Alzheimer’s dementia may nearly triple by 2050 -
11-Mar-2020 8:00 AM EDT Add to Favorites


See All News

Our YouTube Videos

About

The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.

Experts

Contacts

Matt Eaton
Vice President of Communications, Florida Region

meaton@alz.org

407.543.9428

Niles Frantz
Associate Director, PR / Director, News Media Engagement

niles.frantz@alz.org

312-335-5777

Abbey Hunton
Senior Director, Marketing and Communications

aahunton@alz.org

Twitter

close
0.16182